Bespak Europe Ltd:企業の製品パイプライン分析2018

◆英語タイトル:Bespak Europe Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C3017
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator, easfill metered dose inhaler valves and metered dose inhaler valves and actuators. Bespak offers device design and development; device on demand, metrology, rapid prototyping, analytical services, marketing support and lifecycle, program management, and quality and regulatory management services. The company has its presence in Norfolk, Hertfordshire, Cambridge, Milton Keynes and Lancashire. Bespak is headquartered in King’s Lynn, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bespak Europe Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bespak Europe Ltd Company Overview 4
Bespak Europe Ltd Company Snapshot 4
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd – Pipeline Analysis Overview 6
Bespak Europe Ltd – Key Facts 6
Bespak Europe Ltd – Major Products and Services 7
Bespak Europe Ltd Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Overview 10
Bolus Drug Delivery Device 10
Bolus Drug Delivery Device Product Overview 10
DEV610 DPI 11
DEV610 DPI Product Overview 11
IDC300 Integrated Dose Counter 12
IDC300 Integrated Dose Counter Product Overview 12
NAS010 13
NAS010 Product Overview 13
NAS020 – Unidose Nasal Drug Delivery Device 14
NAS020 – Unidose Nasal Drug Delivery Device Product Overview 14
NAS030 Nasal Device 15
NAS030 Nasal Device Product Overview 15
OCU050 Ophthalmic Drug Delivery Device 16
OCU050 Ophthalmic Drug Delivery Device Product Overview 16
VAL020 Metered Dose Inhaler Valve 17
VAL020 Metered Dose Inhaler Valve Product Overview 17
VAL050 pMDI Valve / Actuator 18
VAL050 pMDI Valve / Actuator Product Overview 18
VAL310 Easifill Valve 19
VAL310 Easifill Valve Product Overview 19
Bespak Europe Ltd – Key Competitors 20
Bespak Europe Ltd – Key Employees 21
Bespak Europe Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Bespak Europe Ltd, Recent Developments 23
Oct 17, 2016: Bespak Launches Syrina AR 2.25 Auto-injector For Fully-automatic Delivery Of Viscous Drug Formulations 23
Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 23
Jun 16, 2016: Consort Medical Provides Update on DEV610 development programme 23
Oct 08, 2015: Consort Medical Launches New Brand Identity To The Market 24
Oct 08, 2015: Bespak Launches New Brand Identity To The Market 24
Feb 11, 2015: Bespak Launches Syrina 2.25 At PDA Europe 25
Nov 28, 2013: Major long-term commercial supply contract award – dry powder inhaler 25
Sep 02, 2013: Consort Medical Issues its Interim Management Statement 26
Jul 23, 2013: Bespak Receives Contract To Develop Nasal Drug Delivery Device 26
Jul 22, 2013: Bespak development contract award 26
Appendix 27
Methodology 27
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Indication 5
Bespak Europe Ltd, Key Facts 6
Bespak Europe Ltd, Major Products and Services 7
Bespak Europe Ltd Number of Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Summary by Development Stage 9
Bolus Drug Delivery Device - Product Status 10
Bolus Drug Delivery Device - Product Description 10
DEV610 DPI - Product Status 11
DEV610 DPI - Product Description 11
IDC300 Integrated Dose Counter - Product Status 12
IDC300 Integrated Dose Counter - Product Description 12
NAS010 - Product Status 13
NAS010 - Product Description 13
NAS020 - Unidose Nasal Drug Delivery Device - Product Status 14
NAS020 - Unidose Nasal Drug Delivery Device - Product Description 14
NAS030 Nasal Device - Product Status 15
NAS030 Nasal Device - Product Description 15
OCU050 Ophthalmic Drug Delivery Device - Product Status 16
OCU050 Ophthalmic Drug Delivery Device - Product Description 16
VAL020 Metered Dose Inhaler Valve - Product Status 17
VAL020 Metered Dose Inhaler Valve - Product Description 17
VAL050 pMDI Valve / Actuator - Product Status 18
VAL050 pMDI Valve / Actuator - Product Description 18
VAL310 Easifill Valve - Product Status 19
VAL310 Easifill Valve - Product Description 19
Bespak Europe Ltd, Key Employees 21
Bespak Europe Ltd, Other Locations 22
Glossary 29

List of Figures
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Development Stage 8

★海外企業調査レポート[Bespak Europe Ltd:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novita Healthcare Ltd (NHL):医療機器:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pint Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a pharmaceutical company which develops, manufactures and markets originator drugs focused in rare disease, oncology and specialty pharma. The company offers wide range of products in the form of tablets, inject …
  • Bc Hydro
    Bc Hydro - Strategy, SWOT and Corporate Finance Report Summary Bc Hydro - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ishida Co., Ltd.:企業の戦略・SWOT・財務情報
    Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hyundai Engineering & Construction Co Ltd (000720):電力:M&Aディール及び事業提携情報
    Summary Hyundai Engineering & Construction Co Ltd (Hyundai E&C), a subsidiary of Hyundai Motor Co, is an engineering and construction contracting company. It provides civil and construction works for roads, bridges, harbors, highways and railways. It also undertakes property development of residenti …
  • Invectys SA-製薬・医療分野:企業M&A・提携分析
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company’s product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal a …
  • AECOM (ACM):電力:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • Hochschild Mining plc:企業の戦略・SWOT・財務情報
    Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report Summary Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cambrex Corp (CBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Pro-Dex Inc (PDEX)-医療機器分野:企業M&A・提携分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ING Groep NV:戦略・SWOT・企業財務分析
    ING Groep NV - Strategy, SWOT and Corporate Finance Report Summary ING Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Transcatheter Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Transcatheter Technologies GmbH (Transcatheter) is a medical equipment company that develops aortic valve implantation system. The company develops technologies for self-expanding valve prostheses and endovascular stents through inner catheters. It develops aortic valve implantation system f …
  • Sangam (India) Ltd.:企業の戦略・SWOT・財務分析
    Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ITOCHU Corporation:企業の戦略・SWOT・財務情報
    ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report Summary ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆